←
Serva Health429 posts
Serva Health avatar

Serva Health

@ServaHealthLLC

Delivering world-class patient support programs for the biopharmaceutical and healthcare industries through leading technologies, high-touch nurse call centers

◷ Joined January 2025▧ 231 Photos and videos
Serva Health avatar
Serva Health@ServaHealthLLC·Nov 17

The success of a clinical trial can be influenced by decisions made years before the first patient is enrolled. For the pharmaceutical industry, it's an important reminder that successful clinical research begins long before a trial officially starts. clinicalleader.com/doc/years…

Serva Health avatar
Serva Health@ServaHealthLLC·Nov 12

Faster patient identification doesn't always translate to faster clinical trial enrollment. The opportunity lies in knowing where automation adds value and where personal interaction remains essential. clinicalleader.com/doc/the-r… #PatientRecruitment #ArtificialIntelligence

Serva Health avatar
Serva Health@ServaHealthLLC·Nov 12

Coverage delays shouldn't automatically delay treatment. Pharmaceutical bridge programs can provide eligible patients with temporary medication access while insurance issues are resolved. Learn how bridge programs support treatment continuity: servahealth.com/patient-supp…

Post attachment
Serva Health avatar
Serva Health@ServaHealthLLC·Nov 10

Patient trust is fundamental to effective healthcare, but new research suggests there is still significant work to be done Technology can help improve access and coordination, but meaningful patient relationships are essential fiercepharma.com/marketing/w… #WomensHealth @FiercePharma

Serva Health avatar
Serva Health@ServaHealthLLC·Nov 6

A promising cancer drug can produce results in the lab, but what happens when researchers discover it works for an entirely different reason? Innovation requires more than promising results. It requires understanding why those results occur. pharmavoice.com/news/cancer-… #Oncology

Serva Health avatar
Serva Health@ServaHealthLLC·Nov 3

The conversation around AI in pharma is shifting from what technology could do to what it's actually delivering. The next phase of AI adoption should not be measured by how many tools, but by the improvements those tools can demonstrate pharmtech.com/view/pharma-le…

Serva Health avatar
Serva Health@ServaHealthLLC·Oct 30

Big investments in drug development signal confidence. But confidence and clinical proof are not the same thing. The real measure of progress is not the size of the investment. It is what the science can consistently deliver for patients. Worth a read: pharmavoice.com/news/pharma-…

Serva Health avatar
Serva Health@ServaHealthLLC·Oct 29

The next wave of drug development may come from targeting disease in entirely new ways. For clinical research teams, advancing these innovations will require thoughtful trial design, effective patient recruitment, and strong participant support. pharmavoice.com/news/emergin…

Serva Health avatar
Serva Health@ServaHealthLLC·Oct 23

Administrative burden doesn't end when a form is submitted. Provider teams still face documentation, payer questions, appeals, and follow-up. Patient support programs help clarify ownership and next steps, reducing gaps that pull time away from care. servahealth.com/patient-supp…

Post attachment